Biomarkers in Transplant Recipients to Improve Outcomes
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Pittsburgh
About this trial
The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.
Eligibility criteria
Qualifiers
Recipients of abdominal, thoracic and bone marrow allografts that are receiving inpatient and outpatient follow-up with routine laboratory tests at the University of Pittsburgh Medical Center.
All Ages
Subject or parents are able to read and understand the informed consent
Disqualifiers
Subjects and/or their parents who are unable to read and understand informed consent.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1Children's Hospital of Pittsburgh of UPMC15224, PittsburghPennsylvania, United States
Sponsors and collaborators
University of Pittsburgh
Lead sponsor
Source ClinicalTrials.gov